ArticleVaccines2024
Second-Generation Phage Lambda Platform Employing SARS-CoV-2 Fusion Proteins as a Vaccine Candidate.
Alexis Catala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleVaccines2024
Alexis Catala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.